4-substituted cyclohexyl sulfones as potent, orally active gamma-secretase inhibitors

Bioorg Med Chem Lett. 2006 Jan 15;16(2):280-4. doi: 10.1016/j.bmcl.2005.10.009. Epub 2005 Nov 3.

Abstract

The protease gamma-secretase plays a pivotal role in the synthesis of pathogenic amyloid-beta in Alzheimer's disease (AD). Here, we report a further extension to a series of cyclohexyl sulfone-based gamma-secretase inhibitors which has allowed the preparation of highly potent compounds which also demonstrate robust Abeta(40) lowering in vivo (e.g., compound 32, MED 1mg/kg p.o. in APP-YAC mice).

MeSH terms

  • Administration, Oral
  • Amyloid Precursor Protein Secretases
  • Amyloid beta-Peptides / drug effects
  • Animals
  • Aspartic Acid Endopeptidases
  • Brain / drug effects
  • Brain / metabolism
  • Cyclohexanes / administration & dosage*
  • Cyclohexanes / chemistry
  • Cyclohexanes / pharmacology*
  • Dose-Response Relationship, Drug
  • Endopeptidases / drug effects*
  • Enzyme Inhibitors / chemical synthesis
  • Enzyme Inhibitors / chemistry
  • Enzyme Inhibitors / pharmacology*
  • Mice
  • Molecular Structure
  • Peptide Fragments / drug effects
  • Structure-Activity Relationship
  • Sulfones / administration & dosage*
  • Sulfones / chemistry
  • Sulfones / pharmacology*
  • Time Factors

Substances

  • Amyloid beta-Peptides
  • Cyclohexanes
  • Enzyme Inhibitors
  • Peptide Fragments
  • Sulfones
  • amyloid beta-protein (1-40)
  • Amyloid Precursor Protein Secretases
  • Endopeptidases
  • Aspartic Acid Endopeptidases
  • Bace1 protein, mouse